-
1
-
-
0025282411
-
CD44 is the principal cell surface receptor for hyaluronate
-
Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303
-
(1990)
Cell
, vol.61
, pp. 1303
-
-
Aruffo, A.1
Stamenkovic, I.2
Melnick, M.3
Underhill, C.B.4
Seed, B.5
-
2
-
-
0030588502
-
CD44 one ligand, two functions
-
Aruffo A (1996) CD44 one ligand, two functions. J Clin Invest 98:2191
-
(1996)
J Clin Invest
, vol.98
, pp. 2191
-
-
Aruffo, A.1
-
3
-
-
0035205955
-
Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma
-
Ayhan A, Baykal C, Al A, Ayhan A (2001) Altered CD44 variant 6 expression in FIGO stage IB cervical carcinoma. Gynecol Oncol 83:569
-
(2001)
Gynecol Oncol
, vol.83
, pp. 569
-
-
Ayhan, A.1
Baykal, C.2
Al, A.3
Ayhan, A.4
-
4
-
-
0035090390
-
Overexpression of CD44 variant 6 in human endometrial cancer and is prognostic significance
-
Ayhan A, Tok EC, Bildirici I, Ayhan A (2001) Overexpression of CD44 variant 6 in human endometrial cancer and is prognostic significance. Gynecol Oncol 80:355
-
(2001)
Gynecol Oncol
, vol.80
, pp. 355
-
-
Ayhan, A.1
Tok, E.C.2
Bildirici, I.3
Ayhan, A.4
-
5
-
-
0032414148
-
Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse
-
Beham-Schmid C, Heider KH, Hoefler G, Zatloukal K (1998) Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse. J Pathol 186:383
-
(1998)
J Pathol
, vol.186
, pp. 383
-
-
Beham-Schmid, C.1
Heider, K.H.2
Hoefler, G.3
Zatloukal, K.4
-
7
-
-
0028985177
-
CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor
-
Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A (1995) CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. J Cell Biol 128:687
-
(1995)
J Cell Biol
, vol.128
, pp. 687
-
-
Bennett, K.L.1
Jackson, D.G.2
Simon, J.C.3
Tanczos, E.4
Peach, R.5
Modrell, B.6
Stamenkovic, I.7
Plowman, G.8
Aruffo, A.9
-
8
-
-
0032530514
-
Expression of CD44 variant proteins in adenocarcinoma of Barrett's esophagus and its relation to prognosis
-
Boettger TC, Youssef V, Dutkowski P, Maschek H, Brenner W, Junginger T (1998) Expression of CD44 variant proteins in adenocarcinoma of Barrett's esophagus and its relation to prognosis. Cancer 83:1074
-
(1998)
Cancer
, vol.83
, pp. 1074
-
-
Boettger, T.C.1
Youssef, V.2
Dutkowski, P.3
Maschek, H.4
Brenner, W.5
Junginger, T.6
-
9
-
-
10844290511
-
186 Re-labeled humanized monoclonal antibody BIWA4 (bivatuzumab) in patients with head and neck squamous cell carcinoma
-
186 Re-labeled humanized monoclonal antibody BIWA4 (bivatuzumab) in patients with head and neck squamous cell carcinoma. Clin Cancer Res 9:3961 s
-
(2003)
Clin Cancer Res
, vol.9
-
-
Börjesson, P.1
Postema, E.2
Roos, J.3
Colnot, R.4
Marres, H.5
Van Schie, M.6
Stehle, G.7
De Bree, R.8
Snow, G.9
Oyen, W.10
Van Dongen, M.11
-
11
-
-
0035404863
-
CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression
-
Bourguignon LYW (2001) CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia 6:287
-
(2001)
J Mammary Gland Biol Neoplasia
, vol.6
, pp. 287
-
-
Bourguignon, L.Y.W.1
-
12
-
-
0001518680
-
CD44 Isoform-cytoskeleton interaction in oncogenic signaling and tumor progression
-
Bourguignon LYW, Zhu D, Zhu H (1998) CD44 Isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Frontiers in Bioscience, 3:637
-
(1998)
Frontiers in Bioscience
, vol.3
, pp. 637
-
-
Bourguignon, L.Y.W.1
Zhu, D.2
Zhu, H.3
-
13
-
-
0028957762
-
Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer
-
Brakenhoff RH, van Gog FB, Looney JE, van Walsum M, Snow GB, van Dongen GA (1995) Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer. Cancer Immunol Immunother 40:191
-
(1995)
Cancer Immunol Immunother
, vol.40
, pp. 191
-
-
Brakenhoff, R.H.1
Van Gog, F.B.2
Looney, J.E.3
Van Walsum, M.4
Snow, G.B.5
Van Dongen, G.A.6
-
14
-
-
0033958211
-
Expression of CD44 in uterine cervical squamous neoplasia: A predictor of microinvasion?
-
Callagy G, O'Grady A, Butler D, Leader M, Path FRC, Kay E, Path MRC (2000) Expression of CD44 in uterine cervical squamous neoplasia: a predictor of microinvasion? Gynec Oncol 76:73
-
(2000)
Gynec Oncol
, vol.76
, pp. 73
-
-
Callagy, G.1
O'Grady, A.2
Butler, D.3
Leader, M.4
Path, F.R.C.5
Kay, E.6
Path, M.R.C.7
-
15
-
-
7844252588
-
Expression of human CD44v6 in non-small-cell lung cancer
-
Carbognani P, Spaggiari L, Romani A, Solli P, Corradi A, Cantoni AM, Petronini PG, Borghetti AF, Rusca M, Bobbio P (1998) Expression of human CD44v6 in non-small-cell lung cancer. Eur Surg Res. 30:403
-
(1998)
Eur Surg Res
, vol.30
, pp. 403
-
-
Carbognani, P.1
Spaggiari, L.2
Romani, A.3
Solli, P.4
Corradi, A.5
Cantoni, A.M.6
Petronini, P.G.7
Borghetti, A.F.8
Rusca, M.9
Bobbio, P.10
-
16
-
-
0029849072
-
Differential expression of CD44v6 in adenocarcinoma of the pancreas: An immunohistochemical study
-
Castella EM, Ariza A, Ojanguren I, Mate JL, Roca X, Fernandez-Vasalo A, Navas-Palacios JJ (1996) Differential expression of CD44v6 in adenocarcinoma of the pancreas: an immunohistochemical study. Virchows Arch 429:191
-
(1996)
Virchows Arch
, vol.429
, pp. 191
-
-
Castella, E.M.1
Ariza, A.2
Ojanguren, I.3
Mate, J.L.4
Roca, X.5
Fernandez-Vasalo, A.6
Navas-Palacios, J.J.7
-
17
-
-
0033787185
-
Mortality association of enhanced CD44v6 expression is not mediated through lymphatic spread in stage II colorectal cancer
-
Clarke G, Ryan E, O'Keane JC, Crowe J, Mathuna PM (2000) Mortality association of enhanced CD44v6 expression is not mediated through lymphatic spread in stage II colorectal cancer. J Gastrenterol Hepatol 15:1028
-
(2000)
J Gastrenterol Hepatol
, vol.15
, pp. 1028
-
-
Clarke, G.1
Ryan, E.2
O'Keane, J.C.3
Crowe, J.4
Mathuna, P.M.5
-
18
-
-
0034519646
-
186 Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck
-
186 Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck. J Nucl Med 41:1999
-
(2000)
J Nucl Med
, vol.41
, pp. 1999
-
-
Colnot, D.R.1
Quak, J.J.2
Roos, J.C.3
Van Lingen, A.4
Wilhelm, A.J.5
Van Kamp, G.J.6
Huijgens, P.C.7
Snow, G.B.8
Van Dongen, G.A.9
-
19
-
-
0034978363
-
Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience
-
Colnot DR, Quak JJ, Roos JC, de Bree R, Wilhelm AJ, Snow GB, van Dongen GA (2001) Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experience. Head Neck 23:559
-
(2001)
Head Neck
, vol.23
, pp. 559
-
-
Colnot, D.R.1
Quak, J.J.2
Roos, J.C.3
De Bree, R.4
Wilhelm, A.J.5
Snow, G.B.6
Van Dongen, G.A.7
-
20
-
-
0034847936
-
186Re-cMAb U36 radioimmunotherapy
-
186Re-cMAb U36 radioimmunotherapy. J Nucl Med 2001 42:1364
-
(2001)
J Nucl Med 2001
, vol.42
, pp. 1364
-
-
Colnot, D.R.1
Wilhelm, A.J.2
Cloos, J.3
Roos, J.C.4
De Bree, R.5
Quak, J.J.6
Snow, G.B.7
Van Dongen, G.A.8
-
21
-
-
0036845695
-
186Re-labeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I escalation study
-
186Re-labeled chimeric monoclonal antibody U36 radioimmunotherapy in a phase I escalation study. Clin Cancer Res 8:3401
-
(2002)
Clin Cancer Res
, vol.8
, pp. 3401
-
-
Colnot, D.R.1
Ossenkoppele, G.J.2
Roos, J.C.3
Quak, J.J.4
De Bree, R.5
Borjesson, P.K.6
Huijgens, P.C.7
Snow, G.B.8
Van Dongen, A.G.9
-
22
-
-
0041854151
-
99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck
-
99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 52:576
-
(2003)
Cancer Immunol Immunother
, vol.52
, pp. 576
-
-
Colnot, D.1
Roos, J.2
De Bree, R.3
Wilhelm, A.4
Kummer, J.5
Hanft, G.6
Heider, K.H.7
Stehle, G.8
Snow, G.9
Van Dongen, G.10
-
23
-
-
0031776902
-
CD44v6 expression in human colorectal carcinoma
-
Coppola D, Hyacinthe M, Fu L, Cantor AB, Karl R, Marcet J, Cooper DL, Nicosia SV, Cooper HS (1998) CD44v6 expression in human colorectal carcinoma. Hum Pathol 29:627
-
(1998)
Hum Pathol
, vol.29
, pp. 627
-
-
Coppola, D.1
Hyacinthe, M.2
Fu, L.3
Cantor, A.B.4
Karl, R.5
Marcet, J.6
Cooper, D.L.7
Nicosia, S.V.8
Cooper, H.S.9
-
24
-
-
0019179006
-
Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat
-
Dalchau R, Kirkley J, Fabre JW(1980) Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat. Eur J Immunol 10:737
-
(1980)
Eur J Immunol
, vol.10
, pp. 737
-
-
Dalchau, R.1
Kirkley, J.2
Fabre, J.W.3
-
25
-
-
0028306838
-
Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium
-
Dall P, Heider KH, Hekele A, von Minckwitz G, Kaufmann M, Ponta H, Herrlich P (1994) Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 54:3337
-
(1994)
Cancer Res
, vol.54
, pp. 3337
-
-
Dall, P.1
Heider, K.H.2
Hekele, A.3
Von Minckwitz, G.4
Kaufmann, M.5
Ponta, H.6
Herrlich, P.7
-
26
-
-
0028955619
-
Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer
-
Dall P, Heider KH, Sinn HP, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H (1995) Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 60:471
-
(1995)
Int J Cancer
, vol.60
, pp. 471
-
-
Dall, P.1
Heider, K.H.2
Sinn, H.P.3
Skroch-Angel, P.4
Adolf, G.5
Kaufmann, M.6
Herrlich, P.7
Ponta, H.8
-
27
-
-
0028979238
-
Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with neck and neck cancer
-
de Bree R, Roos JC, Quak JJ, den Hollander W, Snow GB, van Dongen GA (1995). Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with neck and neck cancer. Clin Cancer Res 1:591
-
(1995)
Clin Cancer Res
, vol.1
, pp. 591
-
-
De Bree, R.1
Roos, J.C.2
Quak, J.J.3
Den Hollander, W.4
Snow, G.B.5
Van Dongen, G.A.6
-
28
-
-
0030903526
-
Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients
-
de Bree R, Roos JC, Plaizier MA, Quak JJ, van Kamp GJ, den Hollander W, Snow GB, van Dongen G (1997) Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients. Br J Cancer 75:1049
-
(1997)
Br J Cancer
, vol.75
, pp. 1049
-
-
De Bree, R.1
Roos, J.C.2
Plaizier, M.A.3
Quak, J.J.4
Van Kamp, G.J.5
Den Hollander, W.6
Snow, G.B.7
Van Dongen, G.8
-
29
-
-
0032820878
-
CD44 expression predicts disease outcome in localized large B cell lymphoma
-
Drillenburg P, Wielenga VJM, Kramer MH, van Krieken JH, Kluin-Nelemans HC, Hermans J, Heisterkamp S, Noordijk EM, Kluin PM, Pals ST (1999) CD44 expression predicts disease outcome in localized large B cell lymphoma. Leukemia 13:1448
-
(1999)
Leukemia
, vol.13
, pp. 1448
-
-
Drillenburg, P.1
Wielenga, V.J.M.2
Kramer, M.H.3
Van Krieken, J.H.4
Kluin-Nelemans, H.C.5
Hermans, J.6
Heisterkamp, S.7
Noordijk, E.M.8
Kluin, P.M.9
Pals, S.T.10
-
30
-
-
0031456562
-
Immunohistochemical characterization of E48 and CD44v6 expression in head and neck carcinomas
-
Fabricius EM, Langford A, Bier J, Hell B, Wildner GP, Blümcke S (1997) Immunohistochemical characterization of E48 and CD44v6 expression in head and neck carcinomas. Cancer J 10:325
-
(1997)
Cancer J
, vol.10
, pp. 325
-
-
Fabricius, E.M.1
Langford, A.2
Bier, J.3
Hell, B.4
Wildner, G.P.5
Blümcke, S.6
-
31
-
-
0028672288
-
Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma
-
Figge J, del Rosario AD, Gerasimov G, Dedov I, Bronstein M, Troshina K, Alexandrova G, Kallakury BV, Bui HX, Brataslavsky G (1994) Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma. Exp Mol Pathol 61:203
-
(1994)
Exp Mol Pathol
, vol.61
, pp. 203
-
-
Figge, J.1
Del Rosario, A.D.2
Gerasimov, G.3
Dedov, I.4
Bronstein, M.5
Troshina, K.6
Alexandrova, G.7
Kallakury, B.V.8
Bui, H.X.9
Brataslavsky, G.10
-
32
-
-
0028919576
-
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins
-
Finke LH, Terpe H-J, Zoerb C, Haensch W, Schlag PM (1995) Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 345:583
-
(1995)
Lancet
, vol.345
, pp. 583
-
-
Finke, L.H.1
Terpe, H.-J.2
Zoerb, C.3
Haensch, W.4
Schlag, P.M.5
-
33
-
-
0033064550
-
Prognostic value of CD44 variant expression on primary breast cancer
-
Foekens JA, Dall P, Klijn JGM, Skroch-Angel P, Claassen CJ, Look MP, Ponta H, van Putten WL, Herrlich P, Henzen-Logmans SC (1999) Prognostic value of CD44 variant expression on primary breast cancer. Int J Cancer 84:209
-
(1999)
Int J Cancer
, vol.84
, pp. 209
-
-
Foekens, J.A.1
Dall, P.2
Klijn, J.G.M.3
Skroch-Angel, P.4
Claassen, C.J.5
Look, M.P.6
Ponta, H.7
Van Putten, W.L.8
Herrlich, P.9
Henzen-Logmans, S.C.10
-
34
-
-
0035101810
-
Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: A correlation with histological grade, pattern of stromal invasion, and cell differentiation
-
Fonseca I, Pereira T, Rosa-Santos J, Soares J (2001) Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: a correlation with histological grade, pattern of stromal invasion, and cell differentiation. J Surg Oncol 76:115
-
(2001)
J Surg Oncol
, vol.76
, pp. 115
-
-
Fonseca, I.1
Pereira, T.2
Rosa-Santos, J.3
Soares, J.4
-
35
-
-
0030947576
-
CD44 and its v6 spliced variant in lung tumours
-
Fosano M, Sabatini M, Wieczorek R, Sidhu G, Goswami S, Jagirdar J (1997) CD44 and its v6 spliced variant in lung tumours. Cancer 80:34
-
(1997)
Cancer
, vol.80
, pp. 34
-
-
Fosano, M.1
Sabatini, M.2
Wieczorek, R.3
Sidhu, G.4
Goswami, S.5
Jagirdar, J.6
-
36
-
-
0028133090
-
Normal human tissues, in addition to some tumours, express multiple different CD44 isoforms
-
Fox SB, Fawecett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL (1994) Normal human tissues, in addition to some tumours, express multiple different CD44 isoforms. Cancer Res 54:4539
-
(1994)
Cancer Res
, vol.54
, pp. 4539
-
-
Fox, S.B.1
Fawecett, J.2
Jackson, D.G.3
Collins, I.4
Gatter, K.C.5
Harris, A.L.6
Gearing, A.7
Simmons, D.L.8
-
37
-
-
0033214811
-
Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of non-small cell lung carcinoma with intrapulmonary metastases
-
Fukuse T, Hirata T, Naika H, Hitomi S, Wada H (1999) Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of non-small cell lung carcinoma with intrapulmonary metastases. Cancer 86:1174
-
(1999)
Cancer
, vol.86
, pp. 1174
-
-
Fukuse, T.1
Hirata, T.2
Naika, H.3
Hitomi, S.4
Wada, H.5
-
38
-
-
0028818016
-
Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas
-
Gansauge F, Gansauge S, Zybowalski A, Scharnweber C, Link KH, Nusler AK, Beger HG (1995) Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas. Cancer Res 55:5499
-
(1995)
Cancer Res
, vol.55
, pp. 5499
-
-
Gansauge, F.1
Gansauge, S.2
Zybowalski, A.3
Scharnweber, C.4
Link, K.H.5
Nusler, A.K.6
Beger, H.G.7
-
39
-
-
0031757253
-
Expression of CD44 variants and its association with survival in pancreatic cancer
-
Gotoda T, Matsumura Y, Kondo H, Saitoh D, Shimada Y, Kosuge T, Kanai Y, Kakizoe T (1998) Expression of CD44 variants and its association with survival in pancreatic cancer. Jpn J Cancer Res 89:1033
-
(1998)
Jpn J Cancer Res
, vol.89
, pp. 1033
-
-
Gotoda, T.1
Matsumura, Y.2
Kondo, H.3
Saitoh, D.4
Shimada, Y.5
Kosuge, T.6
Kanai, Y.7
Kakizoe, T.8
-
40
-
-
0034024811
-
Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma
-
Gotoda T, Matsumura Y, Kondo H, Ono H, Kanamoto A, Kato H, Watanabe H, Tachimori Y, Nakanishi Y, Kakizoe T (2000) Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut 46:14
-
(2000)
Gut
, vol.46
, pp. 14
-
-
Gotoda, T.1
Matsumura, Y.2
Kondo, H.3
Ono, H.4
Kanamoto, A.5
Kato, H.6
Watanabe, H.7
Tachimori, Y.8
Nakanishi, Y.9
Kakizoe, T.10
-
41
-
-
0028064699
-
Expression of CD44 splice variants during lymphocyte activation and tumor progression
-
Griffioen AW, Horst E, Heider KH, Wielenga VJM, Adolf GR, Herrlich P, Pals ST (1994) Expression of CD44 splice variants during lymphocyte activation and tumor progression. Cell Adhesion Commun 2:195
-
(1994)
Cell Adhesion Commun
, vol.2
, pp. 195
-
-
Griffioen, A.W.1
Horst, E.2
Heider, K.H.3
Wielenga, V.J.M.4
Adolf, G.R.5
Herrlich, P.6
Pals, S.T.7
-
42
-
-
0029007188
-
CD44 expression and modulation on human neuroblastoma tumors and cell lines
-
Gross N, Beck D, Beretta C, Jackson D, Perruisseau G (1995) CD44 expression and modulation on human neuroblastoma tumors and cell lines. Eur J Cancer 31A:471
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 471
-
-
Gross, N.1
Beck, D.2
Beretta, C.3
Jackson, D.4
Perruisseau, G.5
-
43
-
-
0031948876
-
Expression of splice variants of CD44 in thyroid neoplasms derived from follicular cells
-
Gu J, Daa T, Kashima K, Yokoyama S, Nakayama I, Noguchi S (1998) Expression of splice variants of CD44 in thyroid neoplasms derived from follicular cells. Pathol Int 48:184
-
(1998)
Pathol Int
, vol.48
, pp. 184
-
-
Gu, J.1
Daa, T.2
Kashima, K.3
Yokoyama, S.4
Nakayama, I.5
Noguchi, S.6
-
44
-
-
0025825209
-
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
-
Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13
-
(1991)
Cell
, vol.65
, pp. 13
-
-
Gunthert, U.1
Hofmann, M.2
Rudy, W.3
Reber, S.4
Zoller, M.5
Haussmann, I.6
Matzku, S.7
Wenzel, A.8
Ponta, H.9
Herrlich, P.10
-
46
-
-
0028935205
-
Differential expression of the human metastasis adhesion molecule CD44v in normal and carcinomatous stomach mucosa of Chinese subjects
-
Harn HJ, Ho LI, Chang JY, Wu CW, Jiang SY, Lee HS, Lee WH (1995) Differential expression of the human metastasis adhesion molecule CD44v in normal and carcinomatous stomach mucosa of Chinese subjects. Cancer 5:1065
-
(1995)
Cancer
, vol.5
, pp. 1065
-
-
Harn, H.J.1
Ho, L.I.2
Chang, J.Y.3
Wu, C.W.4
Jiang, S.Y.5
Lee, H.S.6
Lee, W.H.7
-
47
-
-
0027848938
-
Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa
-
Heider KH, Dammrich J, Skroch-Angel P, Mueller-Hermelink HK, Vollmers HP, Herrlich P, Ponta H (1993) Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 53:4197
-
(1993)
Cancer Res
, vol.53
, pp. 4197
-
-
Heider, K.H.1
Dammrich, J.2
Skroch-Angel, P.3
Mueller-Hermelink, H.K.4
Vollmers, H.P.5
Herrlich, P.6
Ponta, H.7
-
48
-
-
0029563794
-
Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and Cynomolgus monkeys
-
Heider KH, Mulder JW, Ostermann E, Susani S, Patzelt P, Pals ST, Adolf GR (1995) Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and Cynomolgus monkeys. Eur J Cancer 31A:2385
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 2385
-
-
Heider, K.H.1
Mulder, J.W.2
Ostermann, E.3
Susani, S.4
Patzelt, P.5
Pals, S.T.6
Adolf, G.R.7
-
50
-
-
0030454435
-
Characterisation of a high affinity monoclonal antibody specific for CD44v6 as a candidate for immunotherapy of squamous cell carcinomas
-
Heider KH, Sproll M, Susani S, Patzelt E, Beaumier P, Ostermann E, Ahorn H, Adolf GR (1996) Characterisation of a high affinity monoclonal antibody specific for CD44v6 as a candidate for immunotherapy of squamous cell carcinomas. Cancer Immunol Immunother 43:245
-
(1996)
Cancer Immunol Immunother
, vol.43
, pp. 245
-
-
Heider, K.H.1
Sproll, M.2
Susani, S.3
Patzelt, E.4
Beaumier, P.5
Ostermann, E.6
Ahorn, H.7
Adolf, G.R.8
-
51
-
-
0029899820
-
Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck
-
Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zoeller J, Bosch FX, Zoller M (1996) Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 179:66
-
(1996)
J Pathol
, vol.179
, pp. 66
-
-
Herold-Mende, C.1
Seiter, S.2
Born, A.I.3
Patzelt, E.4
Schupp, M.5
Zoeller, J.6
Bosch, F.X.7
Zoller, M.8
-
52
-
-
0033941950
-
CD 44 acts both as a growth and invasiveness-promoting molecule and as a tumor-suppressing cofactor
-
Herrlich P, Morrison H, Sleeman J, Orian-Rousseau V, Konig H, Weg-Remers S, Ponta H (2000) CD 44 acts both as a growth and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann N Y Acad Sci 910:106
-
(2000)
Ann N Y Acad Sci
, vol.910
, pp. 106
-
-
Herrlich, P.1
Morrison, H.2
Sleeman, J.3
Orian-Rousseau, V.4
Konig, H.5
Weg-Remers, S.6
Ponta, H.7
-
53
-
-
0032521183
-
Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor
-
Hirata T, Fukuse T, Naiki H, Hitomi S, Wada H (1998) Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Cancer Res 58:1108
-
(1998)
Cancer Res
, vol.58
, pp. 1108
-
-
Hirata, T.1
Fukuse, T.2
Naiki, H.3
Hitomi, S.4
Wada, H.5
-
54
-
-
0032795563
-
Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense γ-enolase expression
-
Iczkowski KA, Shanks JH, Allsbrook WC, Lopez-Beltran A, Pantazis CG, Collins TR, Wetherington RW, Bostwick DG (1999) Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense γ-enolase expression. Histopathology 35:150
-
(1999)
Histopathology
, vol.35
, pp. 150
-
-
Iczkowski, K.A.1
Shanks, J.H.2
Allsbrook, W.C.3
Lopez-Beltran, A.4
Pantazis, C.G.5
Collins, T.R.6
Wetherington, R.W.7
Bostwick, D.G.8
-
55
-
-
0032924221
-
Prognostic significance of CD44v6 in diffuse large B-cell lymphoma
-
Inagaki H, Banno S, Wakita A, Ueda R, Eimoto T (1999) Prognostic significance of CD44v6 in diffuse large B-cell lymphoma. Mod Pathol 12:546
-
(1999)
Mod Pathol
, vol.12
, pp. 546
-
-
Inagaki, H.1
Banno, S.2
Wakita, A.3
Ueda, R.4
Eimoto, T.5
-
56
-
-
0033960402
-
Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma
-
Ishida T (2000) Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma. Jpn J Surg 30:28
-
(2000)
Jpn J Surg
, vol.30
, pp. 28
-
-
Ishida, T.1
-
57
-
-
0028809263
-
Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon
-
Jackson DG, Bell JI, Dickinson R, Timans J, Shields J, Whittle N (1995) Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J Cell Biol 128:673
-
(1995)
J Cell Biol
, vol.128
, pp. 673
-
-
Jackson, D.G.1
Bell, J.I.2
Dickinson, R.3
Timans, J.4
Shields, J.5
Whittle, N.6
-
58
-
-
0031928853
-
CD44v6 is not a prognostic factor in primary breast cancer
-
Jansen RHL, Joosten-Achjanie SR, Arends JW, Volovics A, Hupperets PS, Schouten HC, Hillen HF (1998) CD44v6 is not a prognostic factor in primary breast cancer. Ann Oncol 9:109
-
(1998)
Ann Oncol
, vol.9
, pp. 109
-
-
Jansen, R.H.L.1
Joosten-Achjanie, S.R.2
Arends, J.W.3
Volovics, A.4
Hupperets, P.S.5
Schouten, H.C.6
Hillen, H.F.7
-
59
-
-
0029558983
-
Expression of CD44 splice variants in human primary brain tumors
-
Kaaijk P, Troost D, Morsink F, Keehnen RM, Leenstra S, Bosch DA, Pals ST (1995) Expression of CD44 splice variants in human primary brain tumors. J Neuro-Oncol 26:185
-
(1995)
J Neuro-Oncol
, vol.26
, pp. 185
-
-
Kaaijk, P.1
Troost, D.2
Morsink, F.3
Keehnen, R.M.4
Leenstra, S.5
Bosch, D.A.6
Pals, S.T.7
-
60
-
-
0028882670
-
Prognostic value of CD44 splice variants in human stage III cervical cancer
-
Kainz C, Kohlberger P, Tempfer C, Sliutz G, Gitsch G, Reinthaller A, Breitenecker G (1995) Prognostic value of CD44 splice variants in human stage III cervical cancer. Eur J Cancer 31A:1706
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 1706
-
-
Kainz, C.1
Kohlberger, P.2
Tempfer, C.3
Sliutz, G.4
Gitsch, G.5
Reinthaller, A.6
Breitenecker, G.7
-
61
-
-
0029055027
-
Splice variants of CD44 in human cervical cancer stage IB to IIB
-
Kainz C, Kohlberger P, Sliutz G, Tempfer C, Heinzl H, Reinthaller A, Breitenecker G, Koelbl H (1995) Splice variants of CD44 in human cervical cancer stage IB to IIB. Gynecol Oncol 57:383
-
(1995)
Gynecol Oncol
, vol.57
, pp. 383
-
-
Kainz, C.1
Kohlberger, P.2
Sliutz, G.3
Tempfer, C.4
Heinzl, H.5
Reinthaller, A.6
Breitenecker, G.7
Koelbl, H.8
-
62
-
-
0030017178
-
Immunohistochemical detection of adhesion molecule CD44 splice variants in lymphnode metastasis of cervical cancer
-
Kainz C, Tempfer C, Kohlberger P, Janisch S, Koelbl H, Gitsch G, Breitenecker G (1996) Immunohistochemical detection of adhesion molecule CD44 splice variants in lymphnode metastasis of cervical cancer. Int J Cancer 69:170
-
(1996)
Int J Cancer
, vol.69
, pp. 170
-
-
Kainz, C.1
Tempfer, C.2
Kohlberger, P.3
Janisch, S.4
Koelbl, H.5
Gitsch, G.6
Breitenecker, G.7
-
63
-
-
0034025973
-
Clinicopathological significance of expression of CD44 variants in head and neck squamous cell carcinoma
-
Kanke M, Fujii M, Kameyama K, Kanzaki J, Tokumaru Y, Imanishi Y, Tomita T, Matsumura Y (2000) Clinicopathological significance of expression of CD44 variants in head and neck squamous cell carcinoma. Jpn J Cancer Res 91:410
-
(2000)
Jpn J Cancer Res
, vol.91
, pp. 410
-
-
Kanke, M.1
Fujii, M.2
Kameyama, K.3
Kanzaki, J.4
Tokumaru, Y.5
Imanishi, Y.6
Tomita, T.7
Matsumura, Y.8
-
64
-
-
0029583337
-
Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis
-
Kasper M, Gunthert U, Dall P, Kayser K, Schuh D, Haroske G, Muller M (1995) Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis. Amer J Resp Cell Mol Biol 13:648
-
(1995)
Amer J Resp Cell Mol Biol
, vol.13
, pp. 648
-
-
Kasper, M.1
Gunthert, U.2
Dall, P.3
Kayser, K.4
Schuh, D.5
Haroske, G.6
Muller, M.7
-
65
-
-
0032213888
-
Overexpression of CD44 variants 6 and 7 in human endometrial cancer
-
Katsura M, Furumoto H, Nishmura M, Kamada M, Aono T (1998) Overexpression of CD44 variants 6 and 7 in human endometrial cancer. Gynecol Oncol 71:185
-
(1998)
Gynecol Oncol
, vol.71
, pp. 185
-
-
Katsura, M.1
Furumoto, H.2
Nishmura, M.3
Kamada, M.4
Aono, T.5
-
66
-
-
0030272711
-
Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: Inverse correlation between expression and tumour progression
-
Khaldoyanidi S, Achtnich M, Hehlmann R, Zöller M (1996) Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumour progression. Leukemia Res 20:839
-
(1996)
Leukemia Res
, vol.20
, pp. 839
-
-
Khaldoyanidi, S.1
Achtnich, M.2
Hehlmann, R.3
Zöller, M.4
-
67
-
-
0027523091
-
Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44
-
Koopman G, Heider KH, Horst E, Adolf GR, van de Berg F, Ponta H, Herrlich P, Pals ST (1993) Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 177:897
-
(1993)
J Exp Med
, vol.177
, pp. 897
-
-
Koopman, G.1
Heider, K.H.2
Horst, E.3
Adolf, G.R.4
Van De Berg, F.5
Ponta, H.6
Herrlich, P.7
Pals, S.T.8
-
68
-
-
0028873955
-
Effect of CD44v6 on survival in colorectal carcinoma
-
Koretz K, Moeller P, Lehnert T, Hinz U, Otto HF, Herfarth C (1995) Effect of CD44v6 on survival in colorectal carcinoma. Lancet 345:327
-
(1995)
Lancet
, vol.345
, pp. 327
-
-
Koretz, K.1
Moeller, P.2
Lehnert, T.3
Hinz, U.4
Otto, H.F.5
Herfarth, C.6
-
69
-
-
0031201721
-
Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis
-
Kunishi M, Kayada Y, Yoshiga K (1997) Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis. Int J Oral Maxillofac Surg 26:280
-
(1997)
Int J Oral Maxillofac Surg
, vol.26
, pp. 280
-
-
Kunishi, M.1
Kayada, Y.2
Yoshiga, K.3
-
70
-
-
0031936839
-
Expression of CD44 in premalignant and malignant Barrett's oesophagus
-
Lagorce-Pages C, Paraf F, Dubois S, Belghiti J, Flejou JF (1998) Expression of CD44 in premalignant and malignant Barrett's oesophagus. Histopathology 32:7
-
(1998)
Histopathology
, vol.32
, pp. 7
-
-
Lagorce-Pages, C.1
Paraf, F.2
Dubois, S.3
Belghiti, J.4
Flejou, J.F.5
-
72
-
-
0035141294
-
Alteration of CD44 and cadherins expression: Possible association with augmented aggressiveness and invasiveness of endometrial carcinoma
-
Leblanc M, Poncelet C, Soriano D, Walker-Combrouze F, Madelenat P, Scoazec JY, Darai E (2001) Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma. Virchows Arch 438:78
-
(2001)
Virchows Arch
, vol.438
, pp. 78
-
-
Leblanc, M.1
Poncelet, C.2
Soriano, D.3
Walker-Combrouze, F.4
Madelenat, P.5
Scoazec, J.Y.6
Darai, E.7
-
73
-
-
2642671976
-
A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia
-
Legras S, Gunthert U, Stauder R, Curt F, Oliferenko S, Kluin-Nelemans HC, Marie JP, Proctor S, Jasmin C, Smadja-Joffe F (1998) A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood 91:3401
-
(1998)
Blood
, vol.91
, pp. 3401
-
-
Legras, S.1
Gunthert, U.2
Stauder, R.3
Curt, F.4
Oliferenko, S.5
Kluin-Nelemans, H.C.6
Marie, J.P.7
Proctor, S.8
Jasmin, C.9
Smadja-Joffe, F.10
-
75
-
-
0027491845
-
CD44 and its interaction with extracellular matrix
-
Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54:271
-
(1993)
Adv Immunol
, vol.54
, pp. 271
-
-
Lesley, J.1
Hyman, R.2
Kincade, P.W.3
-
77
-
-
0036736180
-
Expression of CD 44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders
-
Liang X, Smoller BR, Golitz LE (2002) Expression of CD 44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders. J Cutan Pathol 29:459
-
(2002)
J Cutan Pathol
, vol.29
, pp. 459
-
-
Liang, X.1
Smoller, B.R.2
Golitz, L.E.3
-
78
-
-
0035375657
-
Immunohistochemical analysis of CD44 s and CD44v6 in endometriosis and adenomyosis
-
Lin Z, Cho S, Jeong H (2001) Immunohistochemical analysis of CD44 s and CD44v6 in endometriosis and adenomyosis. J Korean Med Sci 16:317
-
(2001)
J Korean Med Sci
, vol.16
, pp. 317
-
-
Lin, Z.1
Cho, S.2
Jeong, H.3
-
79
-
-
0029007805
-
Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential
-
Manten-Horst E, Danen EH, Smit L, Snoek M, Le Poole IC, Van Muijen GN, Pals ST, Ruiter DJ (1995) Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumor progression and metastatic potential. Int J Cancer 64:182
-
(1995)
Int J Cancer
, vol.64
, pp. 182
-
-
Manten-Horst, E.1
Danen, E.H.2
Smit, L.3
Snoek, M.4
Le Poole, I.C.5
Van Muijen, G.N.6
Pals, S.T.7
Ruiter, D.J.8
-
80
-
-
0035234542
-
Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer
-
Mizera-Nyczak E, Dyszkiewicz W, Heider KH (2001) Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer. Tumour Biol 22:45
-
(2001)
Tumour Biol
, vol.22
, pp. 45
-
-
Mizera-Nyczak, E.1
Dyszkiewicz, W.2
Heider, K.H.3
-
81
-
-
0030743447
-
The expression of the CD44 variant exon 6 is associated with lymph node metastases in non-small cell lung cancer
-
Miyoshi T, Kondo K, Hino N, Uyama T, Monden Y (1997) The expression of the CD44 variant exon 6 is associated with lymph node metastases in non-small cell lung cancer. Clin Cancer Res 3:1289
-
(1997)
Clin Cancer Res
, vol.3
, pp. 1289
-
-
Miyoshi, T.1
Kondo, K.2
Hino, N.3
Uyama, T.4
Monden, Y.5
-
82
-
-
0034853807
-
The prognostic significance of CD44 s and CD44v6 expression in stage two breast carcinoma: An immunohistochemical study
-
Morris SF, O'Hanlon DM, Laughlin R, McHale T, Connolly GE, Given HF (2001) The prognostic significance of CD44 s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study. EJSO 27:527
-
(2001)
EJSO
, vol.27
, pp. 527
-
-
Morris, S.F.1
O'Hanlon, D.M.2
Laughlin, R.3
McHale, T.4
Connolly, G.E.5
Given, H.F.6
-
83
-
-
0035871299
-
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44
-
Morrison H, Sherman LS, Legg J. Banine F, Isacke C, Haipek CA, Gutman DH, Ponta H, Herrlich P (2001) The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15:968
-
(2001)
Genes Dev
, vol.15
, pp. 968
-
-
Morrison, H.1
Sherman, L.S.2
Legg, J.3
Banine, F.4
Isacke, C.5
Haipek, C.A.6
Gutman, D.H.7
Ponta, H.8
Herrlich, P.9
-
84
-
-
1842337425
-
Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer
-
Mueller W, Schneiders A, Heider KH, Meier S, Hommel G, Gabbert HE (1997) Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer. J Pathol 183:222
-
(1997)
J Pathol
, vol.183
, pp. 222
-
-
Mueller, W.1
Schneiders, A.2
Heider, K.H.3
Meier, S.4
Hommel, G.5
Gabbert, H.E.6
-
85
-
-
0031751884
-
Comparison of CD44 expression in early colorectal carcinomas of the de novo and ex adenoma types
-
Mueller JD, Heider KH, Oberhuber G, Mueller E, Bethke B, Stolte M, Hofler H (1998) Comparison of CD44 expression in early colorectal carcinomas of the de novo and ex adenoma types. Virchows Arch 433:407
-
(1998)
Virchows Arch
, vol.433
, pp. 407
-
-
Mueller, J.D.1
Heider, K.H.2
Oberhuber, G.3
Mueller, E.4
Bethke, B.5
Stolte, M.6
Hofler, H.7
-
86
-
-
0032847367
-
Expression of adhesion molecules in hepatic metastases of colorectal carcinomas: Relationship to primary tumours and prognosis after hepatic resection
-
Nanashima A, Yamaguchi H, Sawai T, Yasutake T, Tsuji T, Jibiki M, Yamaguchi E, Nakagoe T, Ayabe H (1999) Expression of adhesion molecules in hepatic metastases of colorectal carcinomas: relationship to primary tumours and prognosis after hepatic resection. J Gastroenterol Hepatol 14:1004
-
(1999)
J Gastroenterol Hepatol
, vol.14
, pp. 1004
-
-
Nanashima, A.1
Yamaguchi, H.2
Sawai, T.3
Yasutake, T.4
Tsuji, T.5
Jibiki, M.6
Yamaguchi, E.7
Nakagoe, T.8
Ayabe, H.9
-
87
-
-
0030966842
-
CD44: Structure, function, and association with the malignant process
-
Naor D, Sionov RV, Ish-Sahlom D (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res 71:241
-
(1997)
Adv Cancer Res
, vol.71
, pp. 241
-
-
Naor, D.1
Sionov, R.V.2
Ish-Sahlom, D.3
-
88
-
-
0027101721
-
Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells
-
Neame SJ, Isacke CM (1992) Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. EMBO J 11:4733
-
(1992)
EMBO J
, vol.11
, pp. 4733
-
-
Neame, S.J.1
Isacke, C.M.2
-
89
-
-
0030667213
-
Expression of CD44 isoforms by highly enriched CD34-positive cells in cord blood, bone marrow and leukaphereses
-
Neu S, Geiselhart A, Sproll M, Hahn D, Kuci S, Niethammer D, Handgretinger R (1997) Expression of CD44 isoforms by highly enriched CD34-positive cells in cord blood, bone marrow and leukaphereses. Bone Marrow Transplant 20:593
-
(1997)
Bone Marrow Transplant
, vol.20
, pp. 593
-
-
Neu, S.1
Geiselhart, A.2
Sproll, M.3
Hahn, D.4
Kuci, S.5
Niethammer, D.6
Handgretinger, R.7
-
90
-
-
0033634883
-
CD44 and its v6 spliced variant in lung carcinomas: Relationship to NCAM, CEA, EMA and UP1 and prognostic significance
-
Nguen VN, Mirejovska T, Melinova L, Mandys V (2000) CD44 and its v6 spliced variant in lung carcinomas: relationship to NCAM, CEA, EMA and UP1 and prognostic significance. Neoplasma 47:400
-
(2000)
Neoplasma
, vol.47
, pp. 400
-
-
Nguen, V.N.1
Mirejovska, T.2
Melinova, L.3
Mandys, V.4
-
91
-
-
0030997602
-
The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy
-
Noordzij MA, Steenbrugge GJ van, Verkaik NS, Schroder FH, Kwast TH van der (1997) The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin Cancer Res 3:805
-
(1997)
Clin Cancer Res
, vol.3
, pp. 805
-
-
Noordzij, M.A.1
Van Steenbrugge, G.J.2
Verkaik, N.S.3
Schroder, F.H.4
Van Der Kwast, T.H.5
-
93
-
-
0032866750
-
CD44 is an independent prognostic factor in conventional renal cell carcinomas
-
Paradis V, Ferlicot S, Ghannam E, Zeimoura L, Blanchet P, Eschwege P, Jardin A, Benoit G, Bedossa P (1999) CD44 is an independent prognostic factor in conventional renal cell carcinomas. J Urol 161:1984
-
(1999)
J Urol
, vol.161
, pp. 1984
-
-
Paradis, V.1
Ferlicot, S.2
Ghannam, E.3
Zeimoura, L.4
Blanchet, P.5
Eschwege, P.6
Jardin, A.7
Benoit, G.8
Bedossa, P.9
-
94
-
-
0042787657
-
Progress in immunoconjugate cancer therapeutics
-
Payne G (2003) Progress in immunoconjugate cancer therapeutics. Cancer Cell 3:207
-
(2003)
Cancer Cell
, vol.3
, pp. 207
-
-
Payne, G.1
-
95
-
-
0033804508
-
Reduced expression of CD44v3 variant isoform is associated with unfavourable outcome in non-small cell lung carcinoma
-
Pirinen R. Hirvikoski P, Bohm J, Kellokoski J, Moisio K, Moisio K, Viren M, Johansson R, Hollmen S, Kosma VM (2000) Reduced expression of CD44v3 variant isoform is associated with unfavourable outcome in non-small cell lung carcinoma. Hum Pathol 31:1088
-
(2000)
Hum Pathol
, vol.31
, pp. 1088
-
-
Pirinen, R.1
Hirvikoski, P.2
Bohm, J.3
Kellokoski, J.4
Moisio, K.5
Moisio, K.6
Viren, M.7
Johansson, R.8
Hollmen, S.9
Kosma, V.M.10
-
98
-
-
0036144093
-
CD44 expression in human gliomas
-
Ranuncolo SM, Ladeda V, Specterman S, Varela M, Lastiri J, Morandi A, Matos E, Bal de Kier Joffe E, Puricelli L, Pallotta MG (2002) CD44 expression in human gliomas. J Surg Oncol 79:30
-
(2002)
J Surg Oncol
, vol.79
, pp. 30
-
-
Ranuncolo, S.M.1
Ladeda, V.2
Specterman, S.3
Varela, M.4
Lastiri, J.5
Morandi, A.6
Matos, E.7
Bal De Kier Joffe, E.8
Puricelli, L.9
Pallotta, M.G.10
-
99
-
-
0032956417
-
CD44 expression in sinonasal melanomas: Is loss of isoform expression associated with advanced tumor stage?
-
Regauer S, Ott A, Berghold A, Beham A (1999) CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumor stage? J Pathol 187:184
-
(1999)
J Pathol
, vol.187
, pp. 184
-
-
Regauer, S.1
Ott, A.2
Berghold, A.3
Beham, A.4
-
100
-
-
0029135222
-
CD44v6 expression in non-Hodgkin's lymphoma: An association with low histological grade and poor prognosis
-
Ristamäki R, Joensuu H, Söderström KO, Jalkanen S (1995) CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J Pathol 176:259
-
(1995)
J Pathol
, vol.176
, pp. 259
-
-
Ristamäki, R.1
Joensuu, H.2
Söderström, K.O.3
Jalkanen, S.4
-
101
-
-
0032213087
-
CD44 splice variant expression in clear cell carcinoma of the ovary
-
Rodriguez-Rodriguez L, Sancho-Torres I, Leakey P, Gibbin DG, Comerci JT, Ludlow JW, Mesonero C (1998) CD44 splice variant expression in clear cell carcinoma of the ovary. Gynecol Oncol 71:223
-
(1998)
Gynecol Oncol
, vol.71
, pp. 223
-
-
Rodriguez-Rodriguez, L.1
Sancho-Torres, I.2
Leakey, P.3
Gibbin, D.G.4
Comerci, J.T.5
Ludlow, J.W.6
Mesonero, C.7
-
102
-
-
0027410839
-
The two major CD44 proteins expressed on a metastatic rat tumour cell line are derived from different splice variants: Each one individually suffices to confer metastatic behavior
-
Rudy W, Hofmann M, Schwartz-Albiez R, Zoller M, Heider KH, Ponta H, Herrlich P (1993) The two major CD44 proteins expressed on a metastatic rat tumour cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53:1262
-
(1993)
Cancer Res
, vol.53
, pp. 1262
-
-
Rudy, W.1
Hofmann, M.2
Schwartz-Albiez, R.3
Zoller, M.4
Heider, K.H.5
Ponta, H.6
Herrlich, P.7
-
103
-
-
0027268198
-
Regulated expression of exon v6 containing isoforms of CD44 in man: Downregulation during malignant transformation of tumours of squamocellular origin
-
Salmi K, Gron-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumours of squamocellular origin. J Cell Biol 122:431
-
(1993)
J Cell Biol
, vol.122
, pp. 431
-
-
Salmi, K.1
Gron-Virta, K.2
Sointu, P.3
Grenman, R.4
Kalimo, H.5
Jalkanen, S.6
-
104
-
-
0031052954
-
Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas
-
Satoh K, Shimosegawa T, Koizumi M, Toyota T (1997) Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas. Anticancer Res 17:215
-
(1997)
Anticancer Res
, vol.17
, pp. 215
-
-
Satoh, K.1
Shimosegawa, T.2
Koizumi, M.3
Toyota, T.4
-
105
-
-
0029987561
-
A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer
-
Schumacher U, Horny HP, Horst HA, Patzelt E, Herrlich P, Kaiserling E (1996) A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer. Eur J Surg Oncol 22:259
-
(1996)
Eur J Surg Oncol
, vol.22
, pp. 259
-
-
Schumacher, U.1
Horny, H.P.2
Horst, H.A.3
Patzelt, E.4
Herrlich, P.5
Kaiserling, E.6
-
106
-
-
0027065573
-
Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
-
Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A 89:12160
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 12160
-
-
Screaton, G.R.1
Bell, M.V.2
Jackson, D.G.3
Cornelis, F.B.4
Gerth, U.5
Bell, J.I.6
-
107
-
-
0027254186
-
The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat
-
Screaton GR, Bell MV, Bell JI, Jackson DG (1993) The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268:12235
-
(1993)
J Biol Chem
, vol.268
, pp. 12235
-
-
Screaton, G.R.1
Bell, M.V.2
Bell, J.I.3
Jackson, D.G.4
-
108
-
-
0027408671
-
Prevention of tumour metastasis formation by anti-variant CD44
-
Seiter S, Arch R, Reber S, Komitowski D, Hofmann M, Ponta H, Herrlich P, Matzku S, Zoller M (1993) Prevention of tumour metastasis formation by anti-variant CD44. J Exp Med 177:443
-
(1993)
J Exp Med
, vol.177
, pp. 443
-
-
Seiter, S.1
Arch, R.2
Reber, S.3
Komitowski, D.4
Hofmann, M.5
Ponta, H.6
Herrlich, P.7
Matzku, S.8
Zoller, M.9
-
109
-
-
0029967271
-
Expression of CD44 splice variants in human skin and epidermal tumours
-
Seiter S, Tilgen W, Herrmann K, Schadendorf D, Patzelt E, Moeller P, Zoller M (1996) Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Arch 428:141
-
(1996)
Virchows Arch
, vol.428
, pp. 141
-
-
Seiter, S.1
Tilgen, W.2
Herrmann, K.3
Schadendorf, D.4
Patzelt, E.5
Moeller, P.6
Zoller, M.7
-
110
-
-
0029615311
-
Schwann cell tumors express characteristics patterns of CD44 splice variants
-
Sherman L, Skroch-Angel P, Moll J, Schwechheimer K, Ponta H, Herrlich P, Hofmann M (1995) Schwann cell tumors express characteristics patterns of CD44 splice variants. J Neurooncol 26:171
-
(1995)
J Neurooncol
, vol.26
, pp. 171
-
-
Sherman, L.1
Skroch-Angel, P.2
Moll, J.3
Schwechheimer, K.4
Ponta, H.5
Herrlich, P.6
Hofmann, M.7
-
111
-
-
0030037249
-
Expression of CD44 isoforms in human skin cancer
-
Simon JC, Heider KH, Dietrich A, Wutting C, Schoepf E, Adolf GR, Ponta H, Herrlich P (1996) Expression of CD44 isoforms in human skin cancer. Eur J Cancer 32A:1394
-
(1996)
Eur J Cancer
, vol.32 A
, pp. 1394
-
-
Simon, J.C.1
Heider, K.H.2
Dietrich, A.3
Wutting, C.4
Schoepf, E.5
Adolf, G.R.6
Ponta, H.7
Herrlich, P.8
-
112
-
-
0029085149
-
Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44
-
Sinn HP, Heider KH, Skroch-Angel P, von Minkwitz G, Kaufmann M, Herrlich P (1995) Human mammary carcinomas express homologues of rat metastasis- associated variants of CD44. Breast Cancer Res Treat 36:307
-
(1995)
Breast Cancer Res Treat
, vol.36
, pp. 307
-
-
Sinn, H.P.1
Heider, K.H.2
Skroch-Angel, P.3
Von Minkwitz, G.4
Kaufmann, M.5
Herrlich, P.6
-
113
-
-
0030974685
-
Regulation of CD44v6-containing isoforms during proliferation of normal and malignant ephithelial cells
-
Soukka T, Salmi M, Joensuu H, Hakkinen L, Sointu P, Koulu L, Kalimo K, Klemi P, Grenman R, Jalkanen S (1997) Regulation of CD44v6-containing isoforms during proliferation of normal and malignant ephithelial cells. Cancer Res 57:2281
-
(1997)
Cancer Res
, vol.57
, pp. 2281
-
-
Soukka, T.1
Salmi, M.2
Joensuu, H.3
Hakkinen, L.4
Sointu, P.5
Koulu, L.6
Kalimo, K.7
Klemi, P.8
Grenman, R.9
Jalkanen, S.10
-
114
-
-
0032895887
-
CD44v6 expression is an independent prognostic factor in non-negative FIGO stage cervical carcinoma
-
Speiser P, Kridelka F, Tempfer C, Edwards L, Leodolter S, Kainz C, Hacker NF (1999) CD44v6 expression is an independent prognostic factor in non-negative FIGO stage cervical carcinoma. Int J Gyneol Cancer 9:160
-
(1999)
Int J Gyneol Cancer
, vol.9
, pp. 160
-
-
Speiser, P.1
Kridelka, F.2
Tempfer, C.3
Edwards, L.4
Leodolter, S.5
Kainz, C.6
Hacker, N.F.7
-
115
-
-
0033624181
-
Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients
-
Stroomer JW, Roos JC, Sproll M, Quak JJ, Heider KH, Wilhelm BJ, Castelijns JA, Meyer R, Kwakkelstein MO, Snow GB, Adolf GR, van Dongen GA (2000) Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients. Clin Cancer Res 6:3046
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3046
-
-
Stroomer, J.W.1
Roos, J.C.2
Sproll, M.3
Quak, J.J.4
Heider, K.H.5
Wilhelm, B.J.6
Castelijns, J.A.7
Meyer, R.8
Kwakkelstein, M.O.9
Snow, G.B.10
Adolf, G.R.11
Van Dongen, G.A.12
-
116
-
-
0030271770
-
Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer
-
Tempfer C, Loesch A, Heinzl H, Haeusler G, Hanzal E, Koelbl H, Breitenecker G, Kainz C (1996) Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer 32:2023
-
(1996)
Eur J Cancer
, vol.32
, pp. 2023
-
-
Tempfer, C.1
Loesch, A.2
Heinzl, H.3
Haeusler, G.4
Hanzal, E.5
Koelbl, H.6
Breitenecker, G.7
Kainz, C.8
-
117
-
-
0031929916
-
The prognostic value of CD44 isoform expression in endometrial cancer
-
Tempfer C, Haeusler G, Kaider A, Hefler L, Hanzal E, Reinthaller A, Breitenecker G, Kainz C (1998) The prognostic value of CD44 isoform expression in endometrial cancer. Br J Cancer 77:1137
-
(1998)
Br J Cancer
, vol.77
, pp. 1137
-
-
Tempfer, C.1
Haeusler, G.2
Kaider, A.3
Hefler, L.4
Hanzal, E.5
Reinthaller, A.6
Breitenecker, G.7
Kainz, C.8
-
118
-
-
0031715777
-
CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer
-
Tempfer C, Sliutz G, Haeusler G, Speiser P, Reinthaller A, Breitenecker G, Vavra N, Kainz C (1998) CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer. Br J Cancer 78:1091
-
(1998)
Br J Cancer
, vol.78
, pp. 1091
-
-
Tempfer, C.1
Sliutz, G.2
Haeusler, G.3
Speiser, P.4
Reinthaller, A.5
Breitenecker, G.6
Vavra, N.7
Kainz, C.8
-
119
-
-
0031978072
-
CD44 variant isoform expression and breast cancer prognosis
-
Tokue Y, Matsumura Y, Katsumata N, Watanabe T, Tarin D, Kakizoe T (1998) CD44 variant isoform expression and breast cancer prognosis. Jpn J Cancer Res 89:283
-
(1998)
Jpn J Cancer Res
, vol.89
, pp. 283
-
-
Tokue, Y.1
Matsumura, Y.2
Katsumata, N.3
Watanabe, T.4
Tarin, D.5
Kakizoe, T.6
-
120
-
-
0030806945
-
Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas
-
Tran TA, Kallakury BVS, Sheehan CE, Ross JS (1997) Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas. Hum Pathol 28:809
-
(1997)
Hum Pathol
, vol.28
, pp. 809
-
-
Tran, T.A.1
Kallakury, B.V.S.2
Sheehan, C.E.3
Ross, J.S.4
-
121
-
-
0033525829
-
Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor induced signal transduction through the receptor tyrosine kinase c-Met
-
Van der Voort R, Taher TE, Wielenga VJ, Spaargaren M, Prevo R, Smit L, David G, Hartmann G, Gherardi E, Pals S (1999) Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem 274:6499
-
(1999)
J Biol Chem
, vol.274
, pp. 6499
-
-
Van Der Voort, R.1
Taher, T.E.2
Wielenga, V.J.3
Spaargaren, M.4
Prevo, R.5
Smit, L.6
David, G.7
Hartmann, G.8
Gherardi, E.9
Pals, S.10
-
122
-
-
0029803888
-
Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform
-
Van Hal NL, Van Dongen GA, Rood-Knippels EM, Van Der Valk P, Snow GB, Brakenhoff RH (1996) Monoclonal antibody U36, a suitable candidate for clinical immunotherapy of squamous-cell carcinoma, recognizes a CD44 isoform. Int J Cancer 68:520
-
(1996)
Int J Cancer
, vol.68
, pp. 520
-
-
Van Hal, N.L.1
Van Dongen, G.A.2
Rood-Knippels, E.M.3
Van Der Valk, P.4
Snow, G.B.5
Brakenhoff, R.H.6
-
123
-
-
0032817524
-
Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma
-
Van Hal NL, van Dongen GA, Stigter-van Walsum M, Snow GB, Brakenhoff RH (1999) Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma. Int J Cancer 82:837
-
(1999)
Int J Cancer
, vol.82
, pp. 837
-
-
Van Hal, N.L.1
Van Dongen, G.A.2
Stigter-van Walsum, M.3
Snow, G.B.4
Brakenhoff, R.H.5
-
124
-
-
0027385081
-
A PCR-based method for the analysis of human CD44 splice products
-
Van Weering DH, Baas PD, Bos JL (1993) A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl 3:100
-
(1993)
PCR Methods Appl
, vol.3
, pp. 100
-
-
Van Weering, D.H.1
Baas, P.D.2
Bos, J.L.3
-
125
-
-
18644382388
-
The polycomb group protein EZH2 is involved in progression of prostate cancer
-
Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG; Gosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419:624
-
(2002)
Nature
, vol.419
, pp. 624
-
-
Varambally, S.1
Dhanasekaran, S.M.2
Zhou, M.3
Barrette, T.R.4
Kumar-Sinha, C.5
Sanda, M.G.6
Gosh, D.7
Pienta, K.J.8
Sewalt, R.G.9
Otte, A.P.10
Rubin, M.A.11
Chinnaiyan, A.M.12
-
126
-
-
0037140958
-
Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44v6 in nude mice bearing head-and-neck cancer xenografts
-
Verel I, Heider KH, Siegmund M, Ostermann E, Patzelt E, Sproll M, Snow GB, Adolf GR, van Dongen GA (2002) Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44v6 in nude mice bearing head-and-neck cancer xenografts. Int J Cancer 99:396
-
(2002)
Int J Cancer
, vol.99
, pp. 396
-
-
Verel, I.1
Heider, K.H.2
Siegmund, M.3
Ostermann, E.4
Patzelt, E.5
Sproll, M.6
Snow, G.B.7
Adolf, G.R.8
Van Dongen, G.A.9
-
127
-
-
0031717002
-
Predominant expression of CD44 splice variant v10 in malignant and reactive human lymphocytes
-
Wagner SN, Wagner C, Reinhold U, Funk R, Zoller M, Goos M (1998) Predominant expression of CD44 splice variant v10 in malignant and reactive human lymphocytes. J Invest Dermatol 1998;111:464
-
(1998)
J Invest Dermatol 1998
, vol.111
, pp. 464
-
-
Wagner, S.N.1
Wagner, C.2
Reinhold, U.3
Funk, R.4
Zoller, M.5
Goos, M.6
-
128
-
-
6844259864
-
CD44 splice variants as prognostic markers in colorectal cancer
-
Wielenga VJ, van der Voort R, Mulder JW, Kruyt PM, Weidama WF, Oosting J, Seldenrij CA, van Krimpen C, Offerhaus GJ, Pals ST (1998) CD44 splice variants as prognostic markers in colorectal cancer. Scand J Gastrenterol 33:82
-
(1998)
Scand J Gastrenterol
, vol.33
, pp. 82
-
-
Wielenga, V.J.1
Van Der Voort, R.2
Mulder, J.W.3
Kruyt, P.M.4
Weidama, W.F.5
Oosting, J.6
Seldenrij, C.A.7
Van Krimpen, C.8
Offerhaus, G.J.9
Pals, S.T.10
-
129
-
-
0030925367
-
Preferential histiotypic expression of CD 44-isoforms in human lung cancer
-
Wimmel A, Schilli M, Kaiser U, Havemann K, Ramaswamy A, Brandscheid D, Kogan E, Schuermann M (1997) Preferential histiotypic expression of CD 44-isoforms in human lung cancer. Lung Cancer 16:151
-
(1997)
Lung Cancer
, vol.16
, pp. 151
-
-
Wimmel, A.1
Schilli, M.2
Kaiser, U.3
Havemann, K.4
Ramaswamy, A.5
Brandscheid, D.6
Kogan, E.7
Schuermann, M.8
-
130
-
-
0035009823
-
CD44v6 in gastric carcinoma: A marker of tumor progression
-
Xin Y, Grace A, Gallagher MM, Curran BT, Leader MB, Kay EW (2001) CD44v6 in gastric carcinoma: a marker of tumor progression. Appl Immunohistochem Mol Morphol 9:138
-
(2001)
Appl Immunohistochem Mol Morphol
, vol.9
, pp. 138
-
-
Xin, Y.1
Grace, A.2
Gallagher, M.M.3
Curran, B.T.4
Leader, M.B.5
Kay, E.W.6
-
131
-
-
0032080068
-
The hyaluronan receptor RHAMM regulates extracellular-regulated kinase
-
Zhang S, Chang MCY, Zylka D, Turley S, Harrison R, Turley EA (1998) The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. JBC 273:11342
-
(1998)
JBC
, vol.273
, pp. 11342
-
-
Zhang, S.1
Chang, M.C.Y.2
Zylka, D.3
Turley, S.4
Harrison, R.5
Turley, E.A.6
-
132
-
-
0028864558
-
CD44: Physiological expression of distinct isoforms as evidence for organ-specific metastatsis formation
-
Zöller M (1995) CD44: physiological expression of distinct isoforms as evidence for organ-specific metastatsis formation. J Mol Med 73:425
-
(1995)
J Mol Med
, vol.73
, pp. 425
-
-
Zöller, M.1
|